April 1 (Reuters) - Sectra AB SECTb.ST :
* FDA CLEARANCE-SECTRA'S DIGITAL PATHOLOGY SOLUTION AVAILABLE FOR PRIMARY DIAGNOSTICS AND REMOTE READING IN THE U.S.
* SECTRA AB - HAS RECEIVED A 510(K) CLEARANCE BY US FOOD & DRUG ADMINISTRATION (FDA).
* SECTRA AB - CLEARANCE APPLIES FOR SECTRA DIGITAL PATHOLOGY MODULE, KEY COMPONENT OF SECTRA'S PATHOLOGY SOLUTION, WHEN USED TOGETHER WITH LEICA BIOSYSTEMS' SCANNER AT2 DX